[Ip-health] KEI Requests the NIH to Investigate Failure to Disclose Federal Funding in Opdivo and Keytruda Patents

Claire Cassedy claire.cassedy at keionline.org
Fri Dec 20 10:36:59 PST 2019


https://www.keionline.org/32076

KEI Requests the NIH to Investigate Failure to Disclose Federal Funding in
Opdivo and Keytruda Patents

Posted on December 20, 2019 by Claire Cassedy

On December 20, 2019, Knowledge Ecology International (KEI) filed a request
to the National Institutes of Health (NIH) that it investigate an apparent
failure to disclose federal funding in patents associated with cancer
immunotherapies Opdivo and Keytruda. A court case concluded this year
ordered Dr. Gordon Freeman and Dr. Clive Wood to be added to six patents
related to PD-1/PD-L1 pathways, which are foundational patents for the
cancer immunotherapy treatment. Dr. Freeman’s research benefited from
several NIH grants, as is acknowledged in the papers that were key evidence
in the court case that resulted in him being added to the patents as
inventor.

KEI has asked the NIH to investigate this failure to disclose, as well as
for information regarding our outstanding previous requests regarding
failures to disclose on other inventions.

For more on KEI’s work on non-disclosure of federal funding in medical
technology patents, please see:
https://www.keionline.org/bayh-dole/failure-to-disclose

A PDF of the request is available here:
https://www.keionline.org/wp-content/uploads/KEI_Letter_NIH_Request_Re_NonDisclosure_PD1-PL1_Freeman_20Dec2019.pdf.pdf


More information about the Ip-health mailing list